ARCHIVES

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

This article is from The Cancer Letter archive.

Vol. 20 No. 48 | December 16, 1994

Download PDF Visit The Full Archive

Related Articles

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

November 3, 1989

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

December 26, 2008